Daily non-political popular news in brief.

Novel antigen-cloning technique may boost efforts to develop a melanoma vaccine

Experimental vaccines to help the immune system fight tumors have rarely been designed to directly stimulate helper T cells, one of the body's most critical immune responders, because of the difficult process required to isolate and clone antigens for vaccine development. Now, a new technique may allow scientists to create a melanoma vaccine able to stimulate helper T cells. The approach may also aid in the development of other vaccines against cancers or infectious diseases.

Read more »

Keywords: novel, antigen-cloning, technique, boost, efforts, develop, melanoma, vaccine, antigen, cloning, effort

« Previous | Next »

Similar news on "Novel antigen-cloning technique may boost efforts to develop a melanoma vaccine":

1. Novel vaccine concept developed by scientists at the Wistar Institute
   01-31-2008 · EurekAlert!
   A new vaccine design strategy developed by scientists at the Wistar Institute could help to develop vaccines against diseases like AIDS and cervical cancer. The secret is using a herpes simplex protein called glycoprotein D to block a receptor molecule on antigen-presenting cells. Wistar scientists showed that vaccine vectors made by fusing glycoprotein D with genes from HIV and HPV antigens increase the immune system's response to those antigens in cell cultures and mice.
   Similar news · Read more »
   
2. Harvard scientists partner to develop and distribute new tuberculosis vaccine
   02-17-2007 · EurekAlert!
   Bioengineers and public health researchers at Harvard University have developed a novel spraying method for delivering the most common tuberculosis (TB) vaccine, providing a new low-cost and scaleable technique that offers needle-free delivery and greater stability at room temperature than existing methods. The process could one day provide a better approach for vaccination against TB and help prevent the related spread of HIV/AIDS in the developing world.
   Similar news · Read more »
   
3. PATH Malaria Vaccine Initiative announces partnership to develop novel malaria vaccine
   12-14-2006 · EurekAlert!
   In a move that promises to expand the types of malaria vaccine candidates in clinical development, the PATH Malaria Vaccine Initiative today announced a new partnership with Sanaria Inc., a Maryland company, to accelerate development of a unique malaria vaccine candidate.
   Similar news · Read more »
   
4. Researchers find relief for chronic pain
   01-21-2008 · EurekAlert!
   Researchers in the Department of Medicine and Department of Neurosciences at Mount Sinai School of Medicine have discovered that chronic pain can be successfully treated with novel targeted gene therapy. In an effort to find a more effective treatment for chronic pain, researchers at Mount Sinai developed a gene therapy technique that simulates the pain-killing effect of opiate drugs.
   Similar news · Read more »
   
5. Novel molecules developed at UB can boost vaccine potency
   02-05-2008 · EurekAlert!
   Two novel proteins studied by a University at Buffalo professor of microbiology and immunology appear to have the potential to enhance the production of antibodies against a multitude of infectious agents.
   Similar news · Read more »
   
6. Harvard team creates spray drying technique for TB vaccine
   02-12-2007 · EurekAlert!
   Bioengineers and public health researchers have developed a novel spray drying method for preserving and delivering the most common tuberculosis (TB) vaccine. The spray drying process could one day provide a better approach for vaccination against TB and help prevent the related spread of HIV/AIDS in the developing world.
   Similar news · Read more »
   
7. Researchers develop darkest manmade material
   01-22-2008 · EurekAlert!
   Researchers at Rensselaer Polytechnic Institute and Rice University have created the darkest material ever made by man. The material, a thin coating comprised of low-density arrays of loosely vertically-aligned carbon nanotubes, absorbs more than 99.9 percent of light and one day could be used to boost the effectiveness and efficiency of solar energy conversion, infrared sensors and other devices. The researchers who developed the material have applied for a Guinness World Record for their efforts.
   Similar news · Read more »
   
8. Transdermal vaccine effective in treating Alzheimer's disease in mouse model
   01-22-2007 · EurekAlert!
   A novel needle-free vaccine approach was found safe and effective in clearing brain-damaging plaques from mice bred to develop Alzheimer's disease. The transdermal vaccination may offer a simple, noninvasive way of preventing or treating Alzheimer'swith less potential for adverse immune reactions.
   Similar news · Read more »
   
9. Cancer vaccines -- Taking a jab at cancer by stimulating the immune system
   04-17-2007 · EurekAlert!
   As the first FDA-approved cancer vaccine, designed to protect against human papillomavirus, has moved from scientific discussion to social debate, other vaccine studies are continuing to make progress. While HPV vaccine efforts had the "benefit" of a viral source for the disease, other researchers are developing vaccines for cancers that are not virally based, in an effort to coax the immune system into attacking cancerous cells.
   Similar news · Read more »
   
10. Genomic technologies to identify toxic chemicals should be developed
    10-09-2007 · EurekAlert!
    A new report from the National Research Council recommends that government agencies enhance their efforts to incorporate genomic data into risk assessments of chemicals and medicines, and calls for a concerted effort to fully develop these methods' potential to protect public health.
    Similar news · Read more »